Status:
UNKNOWN
Lupron Sex Offender Therapy
Lead Sponsor:
Schober, Justine, M.D.
Collaborating Sponsors:
TAP Pharmaceutical Products Inc.
Conditions:
Pedophilia
Eligibility:
MALE
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
This study compared cognitive-behavioral psychotherapy with leuprolide acetate (LA) to cognitive-behavioral psychotherapy with saline injections for 12 months. Five white male pedophiles (M age, 50 ye...
Detailed Description
Hormone therapy is aimed at modification of the basic sex drive, whereas cognitive-behavioral psychotherapy targets cognitive processes that precede all events leading to pedophilic behavior. Obsessio...
Eligibility Criteria
Inclusion
- pedohilia admission,healthy,male,adult,ability to have penile response on plethysmography -
Exclusion
- Denial of pedophilia, seizure disorder treated with dilantin or barbiturates, alcoholism, IQ less than 70
- \-
Key Trial Info
Start Date :
October 1 2001
Trial Type :
INTERVENTIONAL
End Date :
August 1 2005
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00220350
Start Date
October 1 2001
End Date
August 1 2005
Last Update
September 22 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamot Medical Center
Erie, Pennsylvania, United States, 16507